SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity
Press Releases
November 14, 2024

SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity

Growth of UK facility will enable clinical-grade manufacturing of drug substances for range of biopharmaceutical products

bradford

The Bradford Era

Local & Social